The Aadi Bioscience, Inc. (NASDAQ:AADI) fourth quarter and full year 2022 earnings call is being conducted by Scott Giacobello, Senior Vice President of Investor Relations and Corporate Communications at Aadi.  The company announced today that it has hired a CFO to lead its clinical development efforts.  The CFO will provide an update on the company's financial performance in the second half of the year.  The CFO will also provide an update on the company's pipeline of clinical trials.  The CFO will be joined by the company's Chief Medical Officer, Dr. Loretta Itri.  The CMO will be assisted by Scott Giacobello, Chief Commercial Officer, and Chief Medical Officer.  The CFO will be assisted by Scott Giacobello.  The CMO will be assisted by Ansu D'Avino, Chief Operating Officer, and Chief Medical Officer.  The SEC appreciates the assistance of the U.S. Oncology, Tempus and Foundation Medicine.  The SEC's Office of Investor Education and Advocacy has issued anÂ Investor AlertÂ to encourage investors toÂ check the background of anyone selling or offering them anÂ adviser toÂ check the background of anyone sellingÂ anÂ adviser toÂ anÂ adviser.Â Investor.govÂ toÂ check the background of anyone selling anÂ adviser toÂ an analystÂ toÂ check the background of someone selling anÂ adviser.Â Investors shouldÂ check the background of anyone selling an analystÂ adviser toÂ check their background.Â The SEC appreciates the assistance ofÂ Investor.govÂ in this matter.Â The SEC's Office of Investor Education and AdvocacyÂ has issued anÂ Investor AlertÂ onÂ toÂ Investors inÂ AdvisersÂ toÂ check the background of people sellingÂ advisers toÂ advisers.Â Investors shouldÂ checkÂ the background of anyone selling or offering anÂ adviser toÂ advisers toÂ check the backgroundÂ of anyone sellingÂ advisers toÂ Advisers toÂ advisers.